Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments.
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Int J Mol Sci. 2023 Sep 11;24(18):13942. doi: 10.3390/ijms241813942.
Models and mechanisms in very low density lipoprotein metabolism.
Packard CJ, Shepherd J.
Eur J Clin Invest. 1985 Apr;15(2):51-2. doi: 10.1111/j.1365-2362.1985.tb00143.x.
The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor.
Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT.
J Atheroscler Thromb. 2004;11(4):200-8. doi: 10.5551/jat.11.200.
Very low density lipoprotein apolipoprotein B metabolism in humans.
Demant T, Shepherd J, Packard CJ.
Klin Wochenschr. 1988 Aug 15;66(16):703-12. doi: 10.1007/BF01726412.
VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly.
Croyal M, Blanchard V, Ouguerram K, Chétiveaux M, Cabioch L, Moyon T, Billon-Crossouard S, Aguesse A, Bernardeau K, Le May C, Flet L, Lambert G, Hadjadj S, Cariou B, Krempf M, Nobécourt-Dupuy E.
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):819-829. doi: 10.1161/ATVBAHA.119.313877. Epub 2020 Feb 6.
High-density lipoprotein turnover.
Nestel PJ.
Am Heart J. 1987 Feb;113(2 Pt 2):518-21. doi: 10.1016/0002-8703(87)90624-7.
Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties.
Packard CJ, Shepherd J, Joerns S, Gotto AM Jr, Taunton OD.
Biochim Biophys Acta. 1979 Feb 26;572(2):269-82. doi: 10.1016/0005-2760(79)90042-0.
Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.
Dallongeville J, Boulet L, Davignon J, Lussier-Cacan S.
Arterioscler Thromb. 1991 Jul-Aug;11(4):864-71. doi: 10.1161/01.atv.11.4.864.
Familial hypertriglyceridemia/polygenic hypertrigliceridemia.
Lahoz C, Mostaza JM.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:37-42. doi: 10.1016/j.arteri.2020.12.014.
Dual defect in metabolism of very-low-density lipoprotein triglycerides. Patients with type 5 hyperlipoproteinemia.
Kesaniemi YA, Grundy SM.
JAMA. 1984 May 18;251(19):2542-7.
